IGC Pharma, Inc. Operating Lease, Liability
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-03-18
- 2025-12-31: Operating Lease, Liability $11.00K.
- 2025-03-31: Operating Lease, Liability $103.00K.
- 2024-03-31: Operating Lease, Liability $208.00K.
- 2023-03-31: Operating Lease, Liability $340.00K.
| Period end | Operating Lease, Liability |
|---|---|
| 2025-12-31 | $11.00K 10-KT · filed 2026-03-18 |
| 2025-03-31 | $103.00K 10-KT · filed 2026-03-18 |
| 2024-03-31 | $208.00K 10-K · filed 2025-06-27 |
| 2023-03-31 | $340.00K 10-K · filed 2024-06-24 |
| 2022-12-31 | $371.00K 10-Q · filed 2023-02-14 |
| 2022-09-30 | $403.00K 10-Q · filed 2022-11-01 |
| 2022-06-30 | $434.00K 10-Q · filed 2022-08-05 |
| 2022-03-31 | $464.00K 10-K · filed 2023-07-07 |
| 2021-12-31 | $494.00K 10-Q · filed 2022-02-10 |
| 2021-09-30 | $521.00K 10-Q · filed 2021-10-29 |
| 2021-06-30 | $547.00K 10-Q · filed 2021-08-11 |
| 2021-03-31 | $495.00K 10-K · filed 2022-06-23 |
| 2020-12-31 | $516.00K 10-Q · filed 2021-02-16 |
| 2020-09-30 | $536.00K 10-Q · filed 2020-11-20 |
| 2020-06-30 | $555.00K 10-Q · filed 2020-08-19 |
| 2020-03-31 | $574.00K 10-K · filed 2021-06-14 |